Cedilla Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- October 25, 2021
- Vertical
- Precision Oncology
- Funding URL
- View Funding Page
- Funding Amount:
- $82,600,000
Company Info
- Company Description
- Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
- Market
- Cancer Treatment
- Location
- Cambridge, MA, USA
- Coinvestors
- Janus Henderson Investors, Logos Capital, RA Capital Management, Third Rock Ventures, Woodline Partners